Granules India signs MoU with PharmaMatch

2433 Investors following Granules India. Share this News with them.

0

Like this story, share it with millions of investors on M3

Granules India signs MoU with PharmaMatch

Granules India signs MOU with PharmaMatch

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Granules pact with Dutch co PharmaMatch Granules India Q1 net up 2.51% at Rs 2.04cr Granules India achieves rise in net sales by 14% ALSO READ See latest News about Granules India See previous management interviews See what other Experts & Brokerages are saying about Granules India Granules India BSE | NSE 25/05/12 Are Mutual Funds betting on Granules India?

PharmaMatch B.V. and Granules India Limited are pleased to announce the signing of a Memorandum of Understanding to develop, manufacture and market formulations in the European Market jointly. 

This arrangement will kick-off with the transfer of existing marketing authorizations by PharmaMatch to Granules for products like Paracetamol where Granules has the basic and the necessary skill sets to deliver the same.  This will use the upcoming finished dosage facility of Granules which is expected to be commissioned and fully operational by May 2007.

Commenting on the development, Mr. Irfan Vazirally, Executive Director, PharmaMatch India, said, "Granules has demonstrated excellent capabilities in pharmaceutical manufacturing and they are counting on their capabilities to take this forward in their new business of finished dosages as well".

Mr. C. Krishna Prasad, Managing Director, Granules India Ltd. said, "PharmaMatch is a renowned finished dosage player in European Union and we expect this relationship to catapult Granules strongly into the European Market. We are expecting this development to expedite the approval process for the finished dosage facility in the European Union". 

Sourced From: Adfactors Public Relations Pvt Ltd